The percentage of ALK-positive cells and the efficacy of first-line alectinib in advanced non-small cell lung cancer: is it a novel factor for stratification? (Turkish Oncology Group Study) Mutlu HizalBurak BilginMehmet Ali Nahit Åžendur Research 01 September 2022 Pages: 4141 - 4148
Regional and national burden of leukemia and its attributable burden to risk factors in 21 countries and territories of North Africa and Middle East, 1990–2019: results from the GBD study 2019 Mahsa Heidari-ForoozanSahar Saeedi MoghaddamFarshad Farzadfar Research 01 September 2022 Pages: 4149 - 4161
Vessels that encapsulate tumor clusters (VETC) pattern predicts the efficacy of adjuvant TACE in hepatocellular carcinoma Jia-hong WangXiao-shan LiShu-Zhong Cui Research 01 September 2022 Pages: 4163 - 4172
Radiation modulates expression and related activities of c-Met protein in oral tongue squamous cell carcinoma cell lines Aisha A. H. Al-JamaeiJan G. A. M. de VisscherMarco N. Helder Research Open access 02 September 2022 Pages: 4173 - 4184
Experience of office-based haematologists and oncologists with outpatient psycho-social support services for cancer patients with and without migration background in Germany Nicola RiccettiIsabelle HemplerSusanne Singer Research Open access 02 September 2022 Pages: 4185 - 4194
Dynamic changes of soluble HLA-G and cytokine plasma levels in cervical cancer patients: potential role in cancer progression and immunotherapy Hui-Hui XuYou-You XieQiu-Yue Han Research Open access 02 September 2022 Pages: 4195 - 4204
Measuring the indirect cost associated with advanced non-small cell lung cancer: a nationwide cross-sectional study in China Yi YangYu XiaYingyao Chen Research Open access 03 September 2022 Pages: 4205 - 4214
Do female and male patients derive similar benefits from approved systemic oncology therapies? A systematic review and meta-analysis Vanessa ArcieroErica McDonaldKelvin K. W. Chan Research 03 September 2022 Pages: 4215 - 4224
A novel organic arsenic derivative MZ2 remodels metabolism and triggers mtROS-mediated apoptosis in acute myeloid leukemia Guopeng ChenWenyan SheFuling Zhou Research 03 September 2022 Pages: 4225 - 4242
Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors in patients with recurrent non-small cell lung cancer after definitive concurrent chemoradiation or radiotherapy Jaewon HyungHyunseok YoonJae Cheol Lee Research 05 September 2022 Pages: 4243 - 4251
Low expression of isocitrate dehydrogenase 1 (IDH1) R132H is associated with advanced pathological features in laryngeal squamous cell carcinoma Nasrin ShayanfarAli Zare-MirzaieFatemeh Tajik Research 05 September 2022 Pages: 4253 - 4267
Assessment of depression, anxiety and fatigue in Tunisian patients in recovery from colon cancer and their impact on quality of life Amal ChamsiFaten EzzaairiSlim Ben Ahmed Research 06 September 2022 Pages: 4269 - 4274
The association between body height and cancer: a retrospective analysis of 784,192 outpatients in Germany Sarah KriegChristoph RoderburgKarel Kostev Research Open access 06 September 2022 Pages: 4275 - 4282
BRAF p.V600E genetic testing based on ultrasound-guided fine-needle biopsy improves the malignancy rate in thyroid surgery: our single-center experience in the past 10 years Lei GongYan LiuKai Liang Research Open access 07 September 2022 Pages: 4283 - 4291
High RIG-I and EFTUD2 expression predicts poor survival in endometrial cancer Susanne BeyerLena MüllerThomas Kolben Research Open access 07 September 2022 Pages: 4293 - 4303
Supportive treatment to chemotherapy with MMC, in patients with ocular surface squamous neoplasia or conjunctival melanocytic tumor Maria Grazia SammarcoMonica Maria PagliaraMaria Antonietta Blasi Research 08 September 2022 Pages: 4305 - 4314
Identification of a new prognostic score for patients with high-grade metastatic GEP-NEN treated with palliative chemotherapy Vivian RoseryStephan MikaStefan Kasper Research Open access 08 September 2022 Pages: 4315 - 4325
Maintenance therapy improves the survival outcomes of patients with metastatic nasopharyngeal carcinoma responding to first-line chemotherapy: a multicentre, randomized controlled clinical study Ying LuHaixin HuangZhou Jiang Research Open access 08 September 2022 Pages: 4327 - 4338
The incidence of unexpected uterine malignancies in hysterectomies carried out for benign indications Yuanyuan DingYana HanXiaorong Shi Research Open access 09 September 2022 Pages: 4339 - 4345
New inflammatory indicators for cell-based liquid biopsy: association of the circulating CD44+/CD24− non-hematopoietic rare cell phenotype with breast cancer residual disease Stefan SchreierPrapaphan BudchartWannapong Triampo Research Open access 13 September 2022 Pages: 4347 - 4358
Delineation of a T-cell receptor CDR3-cancer mutanome aromaticity factor, assessable via blood samples, that facilitates the establishment of survival distinctions in bladder cancer Jacqueline Wahura WaweruKennedy Wanjau MwangiFrancis W. Makokha Research 13 September 2022 Pages: 4359 - 4366
Prognostic value of comprehensive typing based on m6A and gene cluster in TNBC Haoming WuJikun FengXi Wang Research 15 September 2022 Pages: 4367 - 4380
Tumor-infiltrating CD226+CD8+ T cells are associated with postoperative prognosis and adjuvant chemotherapeutic benefits in gastric cancer patients Yu ZhangZhen-xiong ZhaoHua Huang Research 15 September 2022 Pages: 4381 - 4389
C5α secreted by tumor mesenchymal stem-like cells mediates resistance to 5-aminolevulinic acid-based photodynamic therapy against glioblastoma tumorspheres Junseong ParkSeung Jae OhSeok-Gu Kang Research 15 September 2022 Pages: 4391 - 4402
Down-regulated lncRNA ROR in tumor-educated platelets as a liquid-biopsy biomarker for nasopharyngeal carcinoma Jiazhou WeiXian MengHui Wang Research Open access 15 September 2022 Pages: 4403 - 4409
The impact of stereotactic ablative radiotherapy on oligoprogressive metastases from renal cell carcinoma Ciro FranzeseBeatrice MariniMarta Scorsetti Research 15 September 2022 Pages: 4411 - 4417
Novel scoring system guiding the incorporation of adjuvant RT for neuroendocrine neoplasms treated with surgical resection followed by chemotherapy Jeanny KwonByoung Hyuck Kim Research 17 September 2022 Pages: 4419 - 4428
Expression and prognostic signatures of m6A-related lncRNAs in hepatocellular carcinoma Kenan HaoJincheng LiXiaofeng He Research 19 September 2022 Pages: 4429 - 4441
Clinical implications and genetical insights of SOX6 expression in acute myeloid leukemia Yan LiDuanfeng JiangHaigang Shao Research 19 September 2022 Pages: 4443 - 4453
Molecular, clinicopathological characteristics and surgical results of resectable SMARCA4-deficient thoracic tumors Jizhuang LuoBowen DingChunyu Ji Research 19 September 2022 Pages: 4455 - 4463
Plasma autoantibodies IgG and IgM to PD1/PDL1 as potential biomarkers and risk factors of lung cancer Jiaqi LiMan LiuLiping Dai Research 20 September 2022 Pages: 4465 - 4475
Secretome analysis reveals reduced expression of COL4A2 in hypoxic cancer-associated fibroblasts with a tumor-promoting function in gastric cancer Seo-Gyu ParkMi-Jung JiJae-Young Kim Research 20 September 2022 Pages: 4477 - 4487
10-year survival in female breast cancer patients according to ER, PR and HER2 expression: a cancer registry population-based analysis Teresa IntrieriGianfranco ManneschiAdele Caldarella Research 21 September 2022 Pages: 4489 - 4496
Interdisciplinary surgical approach enables complete tumor resection with preservation of neurological function in specific conditions of pediatric solid malignancies Cristian UrlaJörg FuchsSteven W. Warmann Research Open access 21 September 2022 Pages: 4497 - 4507
Modulation of radiosensitivity of DU145 prostate carcinoma cells by simvastatin Verena KorteGuenther GademannHans-Joachim Ochel Research Open access 21 September 2022 Pages: 4509 - 4514
Identification of rs2736099 as a novel cis-regulatory variation for TERT and implications for tumorigenesis and cell proliferation Qiang ShiXin-Xin ZhangChang Sun Research 21 September 2022 Pages: 4515 - 4522
Central nervous systemic efficacy of immune checkpoint inhibitors and concordance between intra/extracranial response in non-small cell lung cancer patients with brain metastasis Sora KangHyehyun JeongShinkyo Yoon Research 22 September 2022 Pages: 4523 - 4532
Immunomodulatory effects of carbon ion radiotherapy in patients with localized prostate cancer Wei HuYulei PeiQing Zhang Research Open access 23 September 2022 Pages: 4533 - 4545
Prediction of TTF-1 expression in non-small-cell lung cancer using machine learning-based radiomics Ruijie ZhangXiankai HuoShicai Zhang Research 23 September 2022 Pages: 4547 - 4554
Persistence with tamoxifen and aromatase inhibitors in Germany: a retrospective cohort study with 284,383 patients Niklas GremkeSebastian GriewingMatthias Kalder Research Open access 23 September 2022 Pages: 4555 - 4562
SDC4-rs1981429 and ATM-rs228590 may provide early biomarkers of breast cancer risk Sofia I. VuorinenRachel K. OkolicsanyiLarisa M. Haupt Research Open access 24 September 2022 Pages: 4563 - 4578
Characteristics and outcome of patients with small bowel adenocarcinoma (SBA) Andreas TeufelNadja M. Meindl-BeinkerMonika Klinkhammer-Schalke Research Open access 26 September 2022 Pages: 4579 - 4590
Characteristics of appendicitis after immune checkpoint inhibitor therapy among cancer patients Antony MathewMalek ShatilaYinghong Wang Research 26 September 2022 Pages: 4591 - 4599
N6-methyladenosine reader YTHDF3 contributes to the aerobic glycolysis of osteosarcoma through stabilizing PGK1 stability Deyin LiuZhong LiYibin Meng Research 28 September 2022 Pages: 4601 - 4610
Intensified cytarabine dose during consolidation in adult AML patients under 65 years is not associated with survival benefit: real-world data from the German SAL-AML registry Maher HanounLeo RuhnkeStudy Alliance Leukemia (SAL) Research Open access 28 September 2022 Pages: 4611 - 4621
The safety and feasibility of preoperative induction therapy of Savolitinib in non-small cell lung cancer patients with MET exon 14 skipping mutation Han-Yu DengXiao-Ming QiuQinghua Zhou Research 28 September 2022 Pages: 4623 - 4628
One-point flow cytometric MRD measurement to identify children with excellent outcome after intermediate-risk BCP-ALL: results of the ALL-MB 2008 study Alexander PopovGuenter HenzeAlexander Karachunskiy Research 28 September 2022 Pages: 4629 - 4637
Serum-derived extracellular vesicles promote the growth and metastasis of non-small cell lung cancer by delivering the m6A methylation regulator HNRNPC through the regulation of DLGAP5 Shanshan ShiTong WuShengbo Yang Research 29 September 2022 Pages: 4639 - 4651
Microwave in situ inactivation in the treatment of bone giant cell tumor: a mid-term descriptive study Xiang JiangJianan ChenFeng Xu Research 03 October 2022 Pages: 4653 - 4661
The area of residual tumor predicts esophageal squamous cell carcinoma prognosis following neoadjuvant chemotherapy Masahiro AdachiNaoki AoyamaShingo Sakashita Research 06 October 2022 Pages: 4663 - 4673